MO361: Erythropoietin Treatment in Acute Kidney Injury (EAKI): A Pragmatic Randomized Clinical Trial

Abstract BACKGROUND AND AIMS Treatment with erythropoietin (EPO) is well established for anemia in chronic kidney disease patients but not well studied in acute kidney injury (AKI). This study aims to assess the transfusion need, renal recovery and all-cause mortality of AKI patients with anemia whe...

Full description

Saved in:
Bibliographic Details
Published in:Nephrology, dialysis, transplantation dialysis, transplantation, 2022-05, Vol.37 (Supplement_3)
Main Authors: Aoun, Mabel, Sleilaty, Ghassan, Boueri, Celine, Younes, Eliane, Gabriel, Kim, Kahwaji, Reine-Marie, Hilal, Najla, Hawi, Jenny, Araman, Rita, Nehme Chelala, Dania, Beaini, Chadia
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract BACKGROUND AND AIMS Treatment with erythropoietin (EPO) is well established for anemia in chronic kidney disease patients but not well studied in acute kidney injury (AKI). This study aims to assess the transfusion need, renal recovery and all-cause mortality of AKI patients with anemia whether treated or not with EPO. METHOD This is a multicenter, randomized, pragmatic controlled clinical trial. It included 134 hospitalized patients with anemia [hemoglobin (Hb)
ISSN:0931-0509
1460-2385
DOI:10.1093/ndt/gfac135.016